Neurobiology and pharmacology of Huntington's disease.
D001921:Brain / Q000378:metabolism / Q000473:pathology; D002336:Carnosine / Q000378:metabolism; D002795:Choline O-Acetyltransferase / Q000378:metabolism; D002799:Cholinergic Fibers / Q000503:physiopathology; D005968:Glutamate Decarboxylase / Q000378:metabolism; D006801:Humans; D006816:Huntington Disease / Q000473:pathology / Q000503:physiopathology* / Q000628:therapy; D001523:Mental Disorders / Q000503:physiopathology; D009068:Movement; D009410:Nerve Degeneration; D009638:Norepinephrine / Q000378:metabolism; D007703:Peptidyl-Dipeptidase A / Q000378:metabolism; D010830:Physostigmine / Q000627:therapeutic use; D011976:Receptors, Muscarinic / Q000378:metabolism; D017981:Receptors, Neurotransmitter / Q000378:metabolism; D012701:Serotonin / Q000378:metabolism; D014149:Tranquilizing Agents / Q000627:therapeutic use; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives / Q000378:metabolism / Q000627:therapeutic use
D011976:Receptors, Muscarinic; D017981:Receptors, Neurotransmitter; D014149:Tranquilizing Agents; D012701:Serotonin; D005680:gamma-Aminobutyric Acid; D002336:Carnosine; D010830:Physostigmine; D002795:Choline O-Acetyltransferase; D007703:Peptidyl-Dipeptidase A; D005968:Glutamate Decarboxylase; D009638:Norepinephrine